PMID- 36066149 OWN - NLM STAT- MEDLINE DCOM- 20220908 LR - 20221214 IS - 2284-0729 (Electronic) IS - 1128-3602 (Linking) VI - 26 IP - 16 DP - 2022 Aug TI - An insight into the prevalence rates of obesity and its related risk factors among the Saudi community in the Hai'l Region. PG - 5755-5762 LID - 29512 [pii] LID - 10.26355/eurrev_202208_29512 [doi] AB - OBJECTIVE: Obesity/overweight is a major preventable cause of morbidity responsible for various health disorders. Thus, the present investigation aimed to estimate the prevalence rates of obesity and its related risk factors among the Saudi community in the Hai'l Region. PATIENTS AND METHODS: In this study, 2,438 participants were randomly recruited in the Hai'l region during a cross-sectional survey. Participants were included based on their body mass index (BMI). Only those with BMI >25 weight (kg)/height (m)2 were included. RESULTS: The overall prevalence rates of overweight and obesity were 61% and 39%. The prevalence rates of males' overweight, obesity, and morbid obesity were 69%, 19%, and 12%, respectively. The prevalence rates of overweight, obesity and morbid obesity among females were 50%, 28%, and 22%, respectively. CONCLUSIONS: Overweight, obesity, and morbid obesity are prevalent in Hai'l region, Northern Saudi Arabia. Overweight/obesity is more prevalent among women, rural inhabitants, less educated people, and adults aged 26-40 years. Hypertension, type 2 diabetes mellitus (T2DM), and deep vein thrombosis (DVT) are significantly obesity-associated risk factors in Saudi Arabia. FAU - Alreshidi, F F AU - Alreshidi FF AD - Department of Family Medicine, College of Medicine, University of Hai'l, Hail, Saudi Arabia. hussaingad5@gmail.com. FAU - Alreshidi, F S AU - Alreshidi FS FAU - Ahmed, H G AU - Ahmed HG LA - eng PT - Journal Article PL - Italy TA - Eur Rev Med Pharmacol Sci JT - European review for medical and pharmacological sciences JID - 9717360 SB - IM MH - Adult MH - Body Mass Index MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2 MH - Female MH - Humans MH - Male MH - *Obesity, Morbid/epidemiology MH - Overweight/epidemiology MH - Prevalence MH - Risk Factors MH - Saudi Arabia/epidemiology EDAT- 2022/09/07 06:00 MHDA- 2022/09/09 06:00 CRDT- 2022/09/06 08:32 PHST- 2022/09/06 08:32 [entrez] PHST- 2022/09/07 06:00 [pubmed] PHST- 2022/09/09 06:00 [medline] AID - 29512 [pii] AID - 10.26355/eurrev_202208_29512 [doi] PST - ppublish SO - Eur Rev Med Pharmacol Sci. 2022 Aug;26(16):5755-5762. doi: 10.26355/eurrev_202208_29512.